RAFAEL HOLDINGS
Rafael Holdings is a company focused on the development of novel cancer therapies. The company invests in novel cancer therapeutics that have the potential to improve and extend the lives of patients Rafael Holdings was established in 2017 and is based in Newark, New Jersey.
RAFAEL HOLDINGS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Newark, New Jersey, United States
Country:
United States
Website Url:
http://www.rafaelholdings.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
104.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Apache Wordpress Plugins Sitelinks Search Box Euro
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-06-21 | Rafael Pharmaceuticals | Rafael Pharmaceuticals acquired by Rafael Holdings | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-06 | Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical Officer |
| 2021-09-14 | Rafael Holdings Appoints Patrick Fabbio as Chief Financial Officer |
Official Site Inspections
http://www.rafaelholdings.com Semrush global rank: 9.66 M Semrush visits lastest month: 118
- Host name: 232.136.229.23.host.secureserver.net
- IP address: 23.229.136.232
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Rafael Holdings"
Rafael Holdings - Home - Rafael Holdings
Rafael Holdings is focused on developing novel cancer and immune therapies.See details»
Board of Directors - Rafael Holdings
Rafael is committed to providing reasonable accommodations for qualified individuals with disabilities and disabled veterans in our job application procedures. If you need assistance due …See details»
Board of Directors - rafaelholdings.irpass.com
Howard S. Jonas has served as Chairman of the Board of Directors of the Company since August 17, 2017 and as Executive Chairman since June 13, 2022 and served as Chief Executive …See details»
Rafael Holdings - Overview, News & Similar companies - ZoomInfo
Aug 2, 2023 · Rafael Holdings is focused on the development of novel cancer and immune metabolism therapeutics. The company owns the Barer Institute, Inc. and is Read more. Is this …See details»
Rafael Holdings - Crunchbase Investor Profile & Investments
Rafael Holdings is a company focused on the development of novel cancer therapies. Rafael Holdings may be growing as evidenced by its recent financial performance.See details»
Investor Overview
November 6, 2024 : Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results: August 22, 2024 : Rafael Holdings and Cyclo Therapeutics Enter into a Definitive …See details»
Rafael Holdings Realigns Leadership Team to Support Earlier Stage ...
NEWARK, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc., (NYSE: RFL), a company focused on developing novel cancer and immune metabolism therapeutics through …See details»
Rafael Holdings Realigns Leadership Team to Support Earlier Stage ...
Nov 22, 2021 · On June 21, 2021, Rafael Pharmaceuticals announced that it has entered into a merger agreement with Rafael Holdings, Inc. to create a publicly traded late-stage clinical …See details»
Rafael Holdings - Investor Relations
NEWARK, N.J., March 11, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), today announced that its Board of Directors has recruited Ameet Mallik to become the company's …See details»
Rafael Holdings Expands Leadership Team with Three Highly …
NEWARK, N.J., Aug. 17, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today …See details»
Rafael Holdings Realigns Leadership Team to Support Earlier
NEWARK, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc., (NYSE: RFL), a company focused on developing novel cancer and immune metabolism therapeutics through …See details»
News Coverage - Rafael Holdings
Rafael is committed to providing reasonable accommodations for qualified individuals with disabilities and disabled veterans in our job application procedures. If you need assistance due …See details»
Rafael Holdings - Home
Rafael Holdings creates value for its stockholders through investments in a portfolio of commercial real estate and in research-driven oncology therapeutics companies – all backed by a strong …See details»
RFL Stock Price & Charts | Rafael Holdings
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the …See details»
Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief …
Oct 6, 2021 · On June 21, 2021, Rafael Holdings, Inc., (NYSE: RFL) announced that it has entered into a merger agreement to acquire full ownership of Rafael Pharmaceuticals, Inc. For …See details»
Rafael Holdings Realigns Leadership Team to Support Earlier
Nov 22, 2021 · On June 21, 2021, Rafael Pharmaceuticals announced that it has entered into a merger agreement with Rafael Holdings, Inc. to create a publicly traded late-stage clinical …See details»
Rafael Holdings, Inc. (RFL) - Yahoo Finance
Find the latest Rafael Holdings, Inc. (RFL) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
William "Bill" Conkling to assume the role of Chief Executive …
Jan 21, 2022 · William (Bill) Conkling will remain with the Company and assume the responsibilities of Chief Executive Officer from Ameet Mallik as of February 1, 2022.See details»
Rafael Holdings Expands Leadership Team with Three Highly …
NEWARK, N.J., Aug. 17, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today …See details»
Rafael Holdings - Press Releases
IDT Corporation (NYSE: IDT) today announced that the record date for the spin-off of its subsidiary, Rafael Holdings, Inc. (Rafael), to IDT stockholders, will be February 15, 2018, and …See details»